This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.
Company Profile:
Vertex Pharmaceuticals Incorporated
Market Cap (USD):
$121.36 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Regeneron Pharmaceuticals, Inc.
Market Cap (USD):
$115.11 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Moderna, Inc.
Market Cap (USD):
$44.44 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Seagen Inc.
Market Cap (USD):
$43.15 B
(Dec. 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Alnylam Pharmaceuticals, Inc.
Market Cap (USD):
$31.75 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Viela Bio, Inc.
Market Cap (USD):
$22.50 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Royalty Pharma plc
Market Cap (USD):
$15.49 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BioMarin Pharmaceutical Inc.
Market Cap (USD):
$15.47 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Sarepta Therapeutics, Inc.
Market Cap (USD):
$14.59 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Neurocrine Biosciences, Inc.
Market Cap (USD):
$13.91 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
United Therapeutics Corporation
Market Cap (USD):
$13.80 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Karuna Therapeutics, Inc.
Market Cap (USD):
$11.94 B
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Insmed Incorporated
Market Cap (USD):
$11.42 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Incyte Corporation
Market Cap (USD):
$11.36 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Bio-Techne Corporation
Market Cap (USD):
$11.26 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Acceleron Pharma Inc.
Market Cap (USD):
$10.56 B
(Nov. 1, 2021)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
OncBioMune Pharmaceuticals, Inc.
Market Cap (USD):
$8.67 B
(Feb. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Legend Biotech Corporation
Market Cap (USD):
$8.37 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Vaxcyte, Inc.
Market Cap (USD):
$8.30 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
ImmunoGen, Inc.
Market Cap (USD):
$8.25 B
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cerevel Therapeutics Holdings, Inc.
Market Cap (USD):
$7.46 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Intra-Cellular Therapies, Inc.
Market Cap (USD):
$7.29 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Blueprint Medicines Corporation
Market Cap (USD):
$6.83 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ionis Pharmaceuticals, Inc.
Market Cap (USD):
$6.73 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Halozyme Therapeutics, Inc.
Market Cap (USD):
$6.56 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cytokinetics, Incorporated
Market Cap (USD):
$6.50 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Exelixis, Inc.
Market Cap (USD):
$6.44 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Arena Pharmaceuticals, Inc.
Market Cap (USD):
$6.17 B
(March 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Revolution Medicines, Inc.
Market Cap (USD):
$6.09 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Madrigal Pharmaceuticals, Inc.
Market Cap (USD):
$5.89 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology